daksh diabetic and cardiac, dalsh cardiac, daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine, orlidip-120 capsule
daksh diabetic and cardiac, dalsh cardiac, daksh pharmaceuticals , daksh pharma panchkula, cardiac pcd franchise, daksh panchkula, cardiac medicine, heart medicine, orlidip-120 capsule

ORLIDIP-120

CAP ORLIDIP-120 (Orlistat 120 mg ) ALU-ALU 1X10
Category: Tag:
Send Enquiry
Introduction:

ORLIDIP-120 Tablet is a prescription medication containing 120 mg of Orlistat, a potent gastrointestinal lipase inhibitor. It is primarily used to aid weight loss in individuals with obesity or overweight conditions. By inhibiting the absorption of dietary fats, ORLIDIP-120 helps reduce caloric intake, supporting weight management efforts.

Product Range & Benefits:
ORLIDIP-120

Composition: Orlistat 120 mg
Packaging: ALU-ALU, 10 x 10 Tablets
Use: ORLIDIP-120 is a lipase inhibitor indicated for weight management in individuals with obesity or overweight conditions.

Key Benefits:

  • Promotes significant weight loss when combined with a reduced-calorie diet.

  • Reduces the absorption of dietary fats by approximately 30%.

  • Helps improve obesity-related risk factors such as hypertension, diabetes, and dyslipidemia.

  • Supports long-term weight maintenance and prevents weight regain.

Indications:

ORLIDIP-120 Tablet is indicated for:

  • Obesity Management: Assists in weight loss for individuals with a body mass index (BMI) ≥30 kg/m².

  • Overweight Conditions: Suitable for individuals with a BMI ≥27 kg/m² who have associated risk factors such as hypertension, diabetes, or dyslipidemia.

  • Weight Maintenance: Helps prevent weight regain after initial weight loss.

Dosage and Administration:

Adults:

  • Recommended Dose: 120 mg orally three times a day with each main meal containing fat.

Administration Tips:

  • Take ORLIDIP-120 during or up to 1 hour after a fat-containing meal.

  • If a meal is missed or contains no fat, the dose can be omitted.

  • Swallow the tablet whole with water; do not crush or chew.

  • Maintain a nutritionally balanced, reduced-calorie diet with approximately 30% of calories from fat.

Precautions and Warnings:

Before initiating ORLIDIP-120 Tablet, inform your healthcare provider if you have:

  • Malabsorption Syndromes: ORLIDIP-120 is contraindicated in chronic malabsorption conditions.

  • Cholestasis: Avoid use in patients with reduced bile flow.

  • Organ Transplantation: Potential interactions with immunosuppressive agents.

  • Pregnancy and Lactation: Not recommended during pregnancy or breastfeeding.

Drug Interactions:

  • May reduce the absorption of fat-soluble vitamins (A, D, E, K); consider supplementation.

  • Potential interactions with cyclosporine, levothyroxine, warfarin, and antiepileptic drugs; monitor therapy accordingly.

Potential Side Effects:

Common Side Effects:

  • Oily or fatty stools

  • Flatulence with discharge

  • Frequent bowel movements

  • Abdominal pain or discomfort

Serious Side Effects:

  • Severe liver injury (rare)

  • Kidney stones

  • Allergic reactions (rash, itching, swelling)

If any serious side effects occur, discontinue use and seek immediate medical attention.

Conclusion:

ORLIDIP-120 Tablet offers an effective pharmacological approach to weight management by inhibiting dietary fat absorption. When used in conjunction with a balanced, reduced-calorie diet and regular physical activity, it can significantly aid in weight loss and improve associated health conditions. Always consult your healthcare provider before starting any new medication.

Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.

For more such product information and similar product category Miscellaneous

You can also contact us  https://diabetes-cardiac.com/contact-us/

Related products